The company is a biomedical enterprise focusing on the frontier field of global biomedicine, based on solving unmet clinical needs, with a full range of drug research and development capabilities, including small molecule chemicals, large molecule biopharmaceuticals and ADC drugs, and has integrated advantages from intermediates, APIs to formulations, and commercial operation capabilities covering the entire life cycle of “R&D, production and marketing”. The company has two major business segments, namely the innovative biopharmaceuticals business and the chemical preparations and proprietary Chinese medicine business segments. The company's main products: propofol medium/long chain fat emulsion injection, propofol emulsion injection, dexmedetomidine hydrochloride injection, medium/long chain fat emulsion injection, ribavirin granules, ornidazole capsules, racecardotl granules, glucose electrolyte effervescent tablets, astragalus granules, and chai yellow granules.
No Data
No Data